Skip to main content

Table 1 Patientscharacteristics

From: The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer

  Screening set (n = 63) Validation set (n = 86)
Characteristics n (%) n (%)
Histology   
Serous 28 (44.4) 86 (100.0)
Non-serous 35 (55.6) 1 -
FIGO   
I 19 (30.2) 6 (7.0)
II 6 (9.5) 4 (4.7)
III 32 (50.8) 61 (70.9)
IV 6 (9.5) 15 (17.4)
Grade   
Grade 1 10 (15.9) 6 (7.0)
Grade 2 20 (31.7) 19 (22.1)
Grade 3 33 (52.4) 61 (70.9)
Residual tumor   
no 35 (55.6) 37 (43.0)
> 0 cm 28 (44.4) 49 (57.0)
ERα   
positive 13 (20.6) 27 (31.4)
negative 49 (77.8) 55 (63.9)
missing 1 (1.5) 4 (4.7)
ERbeta   
positive 45 (71.4) 14 (16.3)
negative 15 (23.8) 68 (79.0)
missing 3 (4.7) 4 (4.7)
PELP1   
positive 48 (76.2) 21 (24.4)
negative 12 (19.0) 61 (70.9)
missing 3 (4.7) 4 (4.7)
  1. 1 Endometrioid: n= 16; Mucinous: n= 9; Undifferentiated carcinoma: n= 7; Clear cell carcinoma: n= 3;